Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$627,559
+$23,548 QoQ
Shares Held
2,471
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3,470
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Silvant Capital Management LLC holds $144,195,613 across 8 Drug Manufacturers - General names. JNJ ranks #4 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
115,077 | $138,026,817 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,811 | $3,316,713 | |
| 3 | ABBV |
AbbVie Inc.
|
4,037 | $1,015,870 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
2,471 | $627,559 | |
| 5 | AMGN |
Amgen Inc
|
1,245 | $450,839 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,887 | $339,208 | |
| 7 | PFE |
Pfizer Inc
|
9,981 | $240,342 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,411 | $178,265 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $627,559 | 2,471 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $604,011 | 2,471 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $511,373 | 2,471 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $458,172 | 2,471 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $377,445 | 2,471 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $409,790 | 2,471 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $357,356 | 2,471 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $400,450 | 2,471 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $361,161 | 2,471 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $390,887 | 2,471 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $387,304 | 2,471 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $384,858 | 2,471 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $408,999 | 2,471 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $383,005 | 2,471 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $436,502 | 2,471 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $403,662 | 2,471 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $438,627 | 2,471 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $437,935 | 2,471 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $422,713 | 2,471 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $399,066 | 2,471 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $407,072 | 2,471 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $406,108 | 2,471 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $388,885 | 2,471 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $367,882 | 2,471 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $347,496 | 2,471 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $324,022 | 2,471 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||